Delve into a biopharma giant's strategy, Eli Lilly. This past year, the company secured regulatory milestones and strategic deals. The post Eli Lilly’s strategy in motion: Beyond diabetes and obesity appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is ...| Labiotech.eu